1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 6,954 6,954 6,548 127 6,675 406 xbrli:pure xbrli:shares iso4217:GBP 05658859 2024-01-01 2025-03-31 05658859 2025-03-31 05658859 2023-12-31 05658859 2023-01-01 2023-12-31 05658859 2023-12-31 05658859 2022-12-31 05658859 bus:Director1 2024-01-01 2025-03-31 05658859 core:WithinOneYear 2025-03-31 05658859 core:WithinOneYear 2023-12-31 05658859 core:ShareCapital 2025-03-31 05658859 core:ShareCapital 2023-12-31 05658859 core:RetainedEarningsAccumulatedLosses 2025-03-31 05658859 core:RetainedEarningsAccumulatedLosses 2023-12-31 05658859 bus:Director1 2023-12-31 05658859 bus:Director1 2025-03-31 05658859 bus:Director1 2022-12-31 05658859 bus:Director1 2023-12-31 05658859 bus:Director1 2023-01-01 2023-12-31 05658859 bus:SmallEntities 2024-01-01 2025-03-31 05658859 bus:AuditExemptWithAccountantsReport 2024-01-01 2025-03-31 05658859 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2025-03-31 05658859 bus:PrivateLimitedCompanyLtd 2024-01-01 2025-03-31 05658859 bus:FullAccounts 2024-01-01 2025-03-31 05658859 core:OfficeEquipment 2024-01-01 2025-03-31 05658859 core:OfficeEquipment 2023-12-31
COMPANY REGISTRATION NUMBER: 05658859
Maclagan Healthcare Limited
Filleted Unaudited Financial Statements
31 March 2025
Maclagan Healthcare Limited
Statement of Financial Position
31 March 2025
31 Mar 25
31 Dec 23
Note
£
£
£
Fixed assets
Tangible assets
5
406
Current assets
Debtors
6
1,039
Cash at bank and in hand
2,169
17,770
-------
--------
2,169
18,809
Creditors: amounts falling due within one year
7
1,828
6,969
-------
--------
Net current assets
341
11,840
----
--------
Total assets less current liabilities
341
12,246
----
--------
Net assets
341
12,246
----
--------
Capital and reserves
Called up share capital
1
1
Profit and loss account
340
12,245
----
--------
Shareholders funds
341
12,246
----
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Maclagan Healthcare Limited
Statement of Financial Position (continued)
31 March 2025
These financial statements were approved by the board of directors and authorised for issue on 30 July 2025 , and are signed on behalf of the board by:
Mr Claxton
Director
Company registration number: 05658859
Maclagan Healthcare Limited
Notes to the Financial Statements
Period from 1 January 2024 to 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 5 Minton Place, Victoria Road, Bicester, Oxon, OX26 6QB.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Office Equipment
-
25% reducing balance
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 1 (2023: 1 ).
5. Tangible assets
Equipment
Total
£
£
Cost
At 1 January 2024
6,954
6,954
Disposals
( 6,954)
( 6,954)
-------
-------
At 31 March 2025
-------
-------
Depreciation
At 1 January 2024
6,548
6,548
Charge for the period
127
127
Disposals
( 6,675)
( 6,675)
-------
-------
At 31 March 2025
-------
-------
Carrying amount
At 31 March 2025
-------
-------
At 31 December 2023
406
406
-------
-------
6. Debtors
31 Mar 25
31 Dec 23
£
£
Other debtors
1,039
----
-------
7. Creditors: amounts falling due within one year
31 Mar 25
31 Dec 23
£
£
Social security and other taxes
176
1,202
Other creditors
1,652
5,767
-------
-------
1,828
6,969
-------
-------
8. Director's advances, credits and guarantees
During the period the director entered into the following advances and credits with the company:
31 Mar 25
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr Claxton
( 4,757)
29,176
( 24,946)
( 527)
-------
--------
--------
----
31 Dec 23
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr Claxton
9,460
10,089
( 24,306)
( 4,757)
-------
--------
--------
-------